Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target

Lucía B Chemes1, Ignacio E Sánchez, Gonzalo de Prat-Gay

  • 1Protein Structure-Function and Engineering Laboratory, Fundación Instituto Leloir and IIBBA-CONICET, Avenida Patricias Argentinas 435, 1405 Buenos Aires, Argentina.

Insights

The retinoblastoma tumor suppressor (Rb) protein interacts with viral oncoproteins like HPV E7. This study reveals the complex kinetics of Rb binding to E7, crucial for understanding cancer mechanisms.

Area of Science:

  • Molecular Biology
  • Virology
  • Biochemistry

Background:

  • The retinoblastoma tumor suppressor (Rb) protein is critical for cell cycle regulation and is implicated in human cancers.
  • Rb interacts with viral oncoproteins containing the LxCxE motif, such as HPV E7, which are key to understanding tumor suppression and gene expression.

Purpose of the Study:

  • To investigate the detailed kinetic mechanisms of retinoblastoma tumor suppressor (Rb) binding to the human papillomavirus (HPV) E7 oncoprotein.
  • To elucidate how the intrinsically disordered nature of E7 and multiple interaction surfaces contribute to the binding kinetics and affinity.

Main Methods:

  • Detailed kinetic analysis of RbAB binding to HPV E7 oncoprotein fragments and full-length E7.
  • Characterization of binding reactions, including association and dissociation rates, and the role of electrostatic interactions and conformational changes.

Main Results:

  • An LxCxE-containing E7 fragment binds Rb via a fast, two-state reaction favored by electrostatics.
  • Full-length E7 exhibits complex, multi-step binding involving conformational changes and a slow rearrangement, influenced by E7's disordered nature.
  • Differences in Rb-E7 affinity between high- and low-risk HPV types correlate with dissociation rates.

Conclusions:

  • The kinetic complexity of Rb-E7 interaction arises from protein plasticity and multiple interaction sites.
  • Fast recognition of the LxCxE motif in intrinsically disordered regions allows viral proteins to outcompete physiological targets.
  • Understanding these binding dynamics is essential for comprehending viral oncoprotein function and developing therapeutic strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...